Article
The impact of postoperative adjuvant therapy on EGFR-mutated stage IA lung adenocarcinoma with micropapillary pathological subtypes.
World journal of surgical oncology - 5 Sept 2024
Cheng Ran, Hao Zhexue, Qiu Li, Zheng Xiang, Huang Sihe, Xian Jianzhao, Huang Haoyang, Li Jianfu, Zhang Zhenhui, Ye Kaiwen, Wu Wentao, Zhang Yaowen, Liu Jun
Abstract excerpt
BACKGROUND: Micropapillary (MPP) adenocarcinoma is considered one of the most aggressive pathological types of lung adenocarcinoma (LADC). This retrospective study aimed to evaluate the prognostic significance and benefit of postoperative adjuvant therapy (PAT) in stage IA LADC patients with different proportions of MPP components. MATERIALS AND METHODS: We retrospectively examined clinical stage IA LADC patients...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
